Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amaya Arrondo-Velasco"'
Autor:
María Calvo-Arbeloa, Ana María Insausti-Serrano, Amaya Arrondo-Velasco, María Teresa Sarobe-Carricas
Publikováno v:
Farmacia Hospitalaria, Vol 44, Iss 2, Pp 62-67 (2020)
Objective: Inflammatory bowel disease comprises a group of chronic relapsing inflammatory disorders affecting the bowel. In the last decade, the advent of biological drugs brought about a drastic change in the treatment of the disease. Adalimumab, go
Externí odkaz:
https://doaj.org/article/1de4ddd4e670422a9cd580312e4e6bcb
Autor:
Ramón, Morillo-Verdugo, Roberto, Collado-Borell, Amaya, Arrondo-Velasco, Marcelo, Domínguez-Cantero, Aurora, Fernández-Polo, Elena, González-Corominas, Esperanza, Gutiérrez, Aránzazu, Linares-Alarcón, María de Los Ángeles, Parro-Martín, Miguel Ángel, Rodríguez-Cabezas, Mar, Gomis-Pastor
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)
To provide a practical guide for the implementation and use of Pharmaceutical Care through Telepharmacy by healthcare professionals and patients in its different scopes of application. To establish a definition of Telepharmacy and describe the techno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cfe94ea2a5a6d250dffaf897c8dfa0e
https://pubmed.ncbi.nlm.nih.gov/36520566
https://pubmed.ncbi.nlm.nih.gov/36520566
Publikováno v:
European journal of hospital pharmacy : science and practice.
To analyse the changes in patient-reported outcomes after starting advanced antirheumatic treatment.The study included all patients who started self-administered biological or targeted synthetic treatments for rheumatoid arthritis between February an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b1f77dc1b72652e69aa2508c5ab21e2
https://pubmed.ncbi.nlm.nih.gov/35228268
https://pubmed.ncbi.nlm.nih.gov/35228268